Mr. Peter Tuxen Bisgaard is not standing for election at the Annual Meeting of Ra Pharmaceuticals, Inc. The Board intends to appoint an independent director to the Audit Committee to replace Mr. Bisgaard effective upon the conclusion of the Annual Meeting.